In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...

Cantor Fitzgerald issued their FY2025 earnings estimates for ARS Pharmaceuticals in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will ...

Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of BridgeBio Pharma in a research report issued to clients and investors on Tuesday, January 21st.

The actual crisis began when the ruthless and aggressive Randy Bashwinger totally corrupted the Berne GOP as chairman, and it will not be over until he and his cohort, Mr. [Dennis] Palow, are out of ...

There were many surprises in the district of Mistelbach. Due to the crisis at the regional hospital, however, it was ...